NEW YORK (GenomeWeb News) – Roche today said that the US Food and Drug Administration approved a new workflow process for the company's Cobas HPV test.

The newly approved workflow option allows for a sample to be processed from the primary sample collection vial directly after it has been used for cytology testing. This allows laboratories to load the same vial used for a ThinPrep Pap test onto the Cobas 4800 system for high-risk human papillomavirus and individual HPV 16 and HPV 18 genotype testing, Roche said.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

A fire at a Manchester hospital may have destroyed lab equipment and data, the Guardian reports.

Researchers generate a genetic database from skeletal remains from the 1845 Franklin Expedition to the Arctic, Live Science reports.

Researchers in China have begun another trial using CRISPR/Cas9 approaches in cancer patients, according to the Wall Street Journal.

In Science this week: human DNA found in sediments from archeological sites lacking bones, and more.